To explore the effect of m6A writers METTL3 on PD-L1-mediated immunosuppression of NSCLC, the levels of METTL3 and IL-18 in CAFs were detected, after METTL3 knockdown or overexpression. This evidence concerns the gene IL18 and non-small cell lung carcinoma.